GlassScriptPhysician profile
Adolfo Flores
NPI 1659714145
$485.58
in general payments reported to CMS, 2019-2025
13 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.00 · 2020: $85.82 · 2021: $15.00 · 2023: $157 · 2024: $31.79 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $89.26 | 2023-2025 | Azstarys |
| Cranial Technologies, INC | $69.42 | 2023-2025 | Doc Band |
| Glaxosmithkline, LLC. | $64.29 | 2023-2024 | Bexsero |
| Neurocrine Biosciences, INC. | $58.77 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $45.09 | 2019-2020 | |
| Ars Pharmaceuticals Operations, INC. | $25.52 | 2025 | Neffy |
| Viiv Healthcare Company | $23.07 | 2023 | Apretude |
| Verrica Pharmaceuticals INC. | $22.80 | 2025 | Ycanth |
| Sanofi-Aventis U.S. LLC | $22.64 | 2025 | |
| Pfizer INC. | $20.00 | 2025 | |
| Merck Sharp & Dohme LLC | $17.13 | 2025 | Vaqta, Gardasil 9, Rotateq |
| Organon LLC | $15.63 | 2023 | Nexplanon |
| Teva Pharmaceuticals USA, INC. | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adolfo Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.